SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.022
AS - Asia 564
EU - Europa 390
SA - Sud America 168
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 49
Totale 2.243
Nazione #
US - Stati Uniti d'America 995
SG - Singapore 218
BR - Brasile 135
VN - Vietnam 107
CN - Cina 94
IT - Italia 88
RU - Federazione Russa 78
SE - Svezia 51
HK - Hong Kong 47
IE - Irlanda 46
BD - Bangladesh 27
CI - Costa d'Avorio 27
DE - Germania 27
FR - Francia 26
IN - India 25
UA - Ucraina 23
GB - Regno Unito 17
CA - Canada 15
FI - Finlandia 13
IQ - Iraq 8
MX - Messico 8
AR - Argentina 7
ID - Indonesia 7
VE - Venezuela 7
ZA - Sudafrica 7
CO - Colombia 5
DZ - Algeria 5
EC - Ecuador 5
MY - Malesia 5
NL - Olanda 5
TR - Turchia 5
MA - Marocco 4
PL - Polonia 4
AT - Austria 3
BO - Bolivia 3
CL - Cile 3
JP - Giappone 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
KR - Corea 2
LT - Lituania 2
SV - El Salvador 2
TH - Thailandia 2
BF - Burkina Faso 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.194
Città #
Ashburn 259
Singapore 129
Chandler 86
San Jose 67
Dublin 46
Hong Kong 46
Fairfield 44
New York 32
Ho Chi Minh City 31
Dallas 30
Boardman 28
Council Bluffs 28
Hanoi 28
The Dalles 28
Abidjan 27
Beijing 26
Jacksonville 25
Houston 21
Lawrence 20
Princeton 20
Lauterbourg 17
Los Angeles 16
Turin 16
Moscow 13
San Diego 13
Seattle 13
Milan 12
Munich 12
Wilmington 12
Washington 11
Chennai 9
Woodbridge 9
São Paulo 8
Turku 8
Buffalo 7
Cambridge 7
London 7
Rio de Janeiro 6
Santa Clara 6
Ann Arbor 5
Chicago 5
Da Nang 5
Montreal 5
San Mateo 5
Baghdad 4
Boston 4
Denver 4
Haiphong 4
Helsinki 4
Johannesburg 4
Macerata 4
Naples 4
Orem 4
Warsaw 4
Columbus 3
Curitiba 3
Frankfurt am Main 3
Hefei 3
La Paz 3
Mexico City 3
Mumbai 3
Paris 3
Porto Alegre 3
Quito 3
San Francisco 3
Shanghai 3
Tokyo 3
Toronto 3
Aparecida de Goiânia 2
Aracaju 2
Atlanta 2
Barranquilla 2
Belo Horizonte 2
Bragança Paulista 2
Brooklyn 2
Bến Tre 2
Casablanca 2
Contagem 2
Culiacán 2
Eelde 2
Guangzhou 2
Guaratinguetá 2
Hải Dương 2
Jaú 2
Joinville 2
La Plata 2
Lagoa Santa 2
Manchester 2
Marche 2
Miano 2
Mountain View 2
Nasiriyah 2
Ninh Bình 2
Oklahoma City 2
Oran 2
Palermo 2
Phoenix 2
Pune 2
Quảng Ngãi 2
Quận Ba 2
Totale 1.394
Nome #
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 167
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 141
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 139
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 136
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 121
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 119
Role of STAT3 pathway in genitourinary tumors 114
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 113
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 110
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 103
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 102
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 99
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 95
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 94
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 90
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 89
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 89
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 87
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 84
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 76
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 75
Totale 2.243
Categoria #
all - tutte 12.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022130 0 5 4 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/2025432 29 24 5 10 23 55 86 20 69 16 36 59
2025/20261.028 95 47 47 74 129 62 172 101 86 74 89 52
2026/202739 12 27 0 0 0 0 0 0 0 0 0 0
Totale 2.243